CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 309 enrolled
Drug / intervention
Serum Chromium Levelother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06334042
NCT06334042N/ACompleted

Examination of the Effects of Chromium Levels on Glucose Metabolism, Lipid Metabolism, Morbidity and Mortality Rates in Patients Followed in Intensive Care Unit

Oguzhan Kahveci·observational·Posted Mar 27, 2024·Updated Apr 13, 2025

In Brief

An observational study evaluating Serum Chromium Level for Chromium Deficiency and 3 related conditions. Completed, enrolled 309 participants across 1 site.

Detailed Summary

The goal of this observational study is to determine the effects of chromium serum levels on glucose metabolism, lipid metabolism, morbidity and mortality rates in critically ill intensive care patients. The investigators' goal is to provide a different perspective on solving the common problems of hyperglycemia and dyslipidemia encountered in intensive care patients, aiming to reduce morbidity and mortality rates. Participants will give a single blood sample (into trace element serum sample tube) on the day of admission to the intensive care unit, along with routine blood tests, and samples will be taken once a week during their stay in the intensive care unit.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedMar 27, 2024
Enrollment StartFeb 7, 2024
Primary CompletionAug 8, 2024
Study CompletionAug 14, 2024
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 2.3 years ago

Interventions

Serum Chromium Levelother

Measuring serum chromium levels from patients who admitted in intensive care unit.